That’s a wrap! 🙌 Watch our satellite symposium on demand on the ESC365 congress platform and see you next year at #ESCCongress! #Novartis #ESC2024 FA-11261923 August 2024
About us
Committed to providing medical & scientific disease education to healthcare professionals globally. See our community guidelines: https://bit.ly/3PAq2J7 If you have a medical inquiry, please contact your local Novartis Medical contact via https://www.novartis.com/healthcare-professionals/novartis-medical-information. Our posts are for healthcare professionals only. • Please be patient; sometimes responses take time. • Please do not include your personal information in your posts. • We will respond to your questions/comments M-F, 9a-5p CET (no holidays). • The purpose of our posts is to share disease state education, medical information and scientific data, and congress updates. We reserve the right to hide or remove any post that mentions specific product(s) or treatment(s) as that is not the intent of our posts. • If needed, we’ll show you how to get us your contact and case info securely. • We reserve the right to engage with posts on a case-by-case basis; not all posts will be acknowledged or responded to. • Novartis Innovative Medicines does not endorse and is not responsible for the content of third-party links we may share. • Replying to or mentioning users does not imply our endorsement. For US healthcare professionals, please check our dedicated page: Novartis US Medical: https://www.linkedin.com/showcase/novartis-us-medical/
- Website
-
https://www.novartis.com/
External link for Novartis Medical
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
Updates
-
Join #Novartis at #ESCCongress for a Late-Breaking Clinical Trial Presentation of the Novartis-sponsored INTERASPIRE study. Prof. Kausik K. Ray will offer a global perspective on Lp(a) levels in patients with CHD. Don’t miss this discussion! Date: Sunday, September 1st, 2024 Time: 14:45 BST Location: Bishkek – Lecture room #ESC2024 FA-11261920 August 2024
-
#Novartis is proud to present the latest research at #ESCCongress 2024 💪 Don’t miss the upcoming poster presentations from Novartis-sponsored research to learn about the most recent studies on Lipoprotein(a) and ASCVD among different populations. Explore our data and engage with our experts onsite!👇 https://lnkd.in/dzX8xrnW FA-11261930 August 2024
-
-
Heading to #ESCCongress? Join #Novartis Satellite Symposium "Lp(a): Not so 'Little' Anymore", where Dr. Cegla, Prof. Dr. Ballantyne, Prof. Dr. Kronenberg and Prof. Dr. Gouni-Berthold will discuss the critical role of Lp(a) in increasing cardiovascular risk, the importance of testing for Lp(a) and the immediate actions that can be taken to reduce that risk. Don’t miss it if you are on-site in London or follow the live session online on the ESC congress platform. #ESC2024 https://lnkd.in/eruM4q3k FA-11261931 August 2024
-
-
Save the date! 📅 #Novartis will be at #ESCCongress 2024 in London from August 30th - September 2nd. Visit Booth #C300 at ExCeL London and join us onsite or online as we shape the future of medicine together. 💪 https://lnkd.in/dKqpgquB FA-11261916 August 2024
-
Chronic myeloid leukemia (CML) is a type of cancer that affects the blood and bone marrow, where blood cells are made. Recognizing the symptoms of CML is crucial for early detection. These can include fatigue, weight loss, fever, and an enlarged spleen causing discomfort on the left side of the abdomen. Taking proactive steps with your healthcare provider for regular check-ups and monitoring can be beneficial, leading to better disease management and improved quality of life (#QoL). Learn more about CML and its management here: https://lnkd.in/dVYwxFTj
-
Thank you for joining us at our #EHA2024 Satellite Symposium to discuss novel treatment strategies for resolving unmet needs on immune thrombocytopenia (ITP) and warm autoimmune hemolytic anemia (wAIHA). Missed the presentation? Available on demand until August 15th, 2024. https://lnkd.in/dWZZErQh #Novartis #Hematology
-
-
At Novartis, our long-standing commitment to patients living with chronic myeloid leukemia (CML) spans more than two decades, marked by breakthroughs that have helped turn what was once a life-limiting condition into a chronic one for many. Yet, there's more ground to cover. Despite advancements, many patients still face hurdles such as lower response rates, treatment resistance, and intolerance, and have poor quality of life. That’s why we’re committed to continuing to pioneer targeted treatments for CML, and ensuring every patient has access to innovative medicines. Learn more here: https://lnkd.in/daK2pMbM
-
The Novartis #paroxysmalnocturnalhemoglobinuria symposium is now available on demand! Join us on the #EHA2024 Congress platform where the session will be available until 15 August. https://lnkd.in/dDnHp8kw
-
-
Thank you for joining us at #EHA2024 to learn more about our commitment to improve the quality of life of CML patients! If you missed our #CML Satellite Symposium, now is available on demand until August 15th, 2024👇 https://lnkd.in/d-fNgwJr #Novartis #Hematology
-